Olivier Danos is Chief Scientific Officer of Regenxbio Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | RGNX Regenxbio | Common Stock | Grant | Acquire A | No | No | 0 | 38,462 | 0.00 | 124,853 |
2 Jan 24 | RGNX Regenxbio | Common Stock | Payment of exercise | Dispose F | No | No | 17.95 | 8,410 | 150.96 k | 86,391 |
2 Jan 24 | RGNX Regenxbio | Stock Options Common Stock | Grant | Acquire A | No | No | 18.34 | 61,050 | 1.12 mm | 61,050 |
30 Jun 23 | RGNX Regenxbio | Common Stock | Grant | Acquire A | No | No | 16.9915 | 1,123 | 19.08 k | 94,801 |
3 Jan 23 | RGNX Regenxbio | Common Stock | Grant | Acquire A | No | No | 0 | 65,930 | 0.00 | 92,950 |
3 Jan 23 | RGNX Regenxbio | Common Stock | Payment of exercise | Dispose F | No | No | 22.68 | 2,058 | 46.68 k | 27,020 |
3 Jan 23 | RGNX Regenxbio | Stock Options Common Stock | Grant | Acquire A | No | No | 22.25 | 52,986 | 1.18 mm | 52,986 |
30 Jun 22 | RGNX Regenxbio | Common Stock | Grant | Acquire A | No | No | 20.995 | 728 | 15.28 k | 93,678 |